A mouse preprint shows that CAR-T cell therapy reduces cognitive impairment and neuroinflammation in aging, and improves cognitive function and reduces border-associated macrophages in aging and Alzheimer's disease.
14 findings in 9 papers from 2022 to 2026, 4 of them since August 2026
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
1 lab in 1 country
Funders: National Cancer Institute and 4 more
Humans2
Animals5
What did studies of CAR-T cell therapy find?
11
Studies of CAR-T cell therapy measured 11 outcomes, among them cognitive impairment, neuroinflammation and border-associated macrophage.
Cognitive impairment
↓downin mice1
1 study
CAR-T cell therapy decreases cognitive impairment in mice (aging).
“either intravenous CAR T cells, which do not infiltrate the brain, or through transplantation of CAR T-treated progenitors is sufficient to reduce neuroinflammation and cognitive impairment”
CAR-T cell therapy decreases neuroinflammation in mice (aging).
“targeting of aged inflammatory bone marrow myeloid progenitors through either intravenous CAR T cells, which do not infiltrate the brain, or through transplantation of CAR T-treated progenitors is sufficient to reduce neuroinflammation”
CAR-T cell therapy decreases autoimmune disease in severe autoimmune disease.
“early reports of dramatic clinical responses to CAR-T cells targeting CD19+ B cells in patients with severe autoimmune disease raise the possibility that this approach could lead to durable remissions”
Clearing these peripheral myeloid cells remodeled brain macrophages and improved cognitive performance without requiring the engineered immune cells to enter the brain.Clearing these peripheral myeloid cells remodeled brain macrophages and improved cognitive performance without requiring the engineered immune cells to enter the brain.